Post-Marketing Observational Study of the Impact of Adherence to Treatment With Once-Daily Administered Long-Acting Bronchodilators (LABAs / LAMAs) on Patients Health Related Quality of Life in COPD Patients
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2018
Price : $35 *
At a glance
- Drugs Tiotropium bromide (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 03 Mar 2017 Status changed from active, no longer recruiting to completed.
- 06 Sep 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 06 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.